Urine Analysis in Monoclonal Gammopathies: New Cut-off Values
Author Information
Author(s): Mònica Vidal-Pla, Elisa Nuez-Zaragoza, Indira Bhambi, Vicente Aguadero
Primary Institution: Parc Taulí University Hospital, Universitat Autònoma de Barcelona, Sabadell, Barcelona, Spain
Hypothesis
When the serum M-protein concentration of a patient is low in the first laboratory analysis of a gammopathy, the probability of finding M-protein in urine is also low.
Conclusion
Setting cut-off values for serum M-protein can significantly reduce unnecessary urine analyses in patients with monoclonal gammopathies.
Supporting Evidence
- The study found that a serum M-protein cut-off of ≤3.5 g/L with eGFR >30 mL/min/1.73 m2 results in a 100% negative predictive value for urine M-protein.
- Patients with alpha heavy chain had a higher probability of having M-protein in urine compared to those with gamma or mu heavy chains.
- The study suggests that urine analysis could be avoided in a significant number of cases, optimizing healthcare resources.
Takeaway
If a patient's blood test shows low levels of a certain protein, we might not need to check their urine for that protein, which saves time and resources.
Methodology
A retrospective study analyzing data from 132 patients with newly diagnosed serum M-protein, comparing groups based on urine M-protein presence.
Limitations
The study was conducted in a specific group of patients with first detection of serum M-protein, which may not generalize to other patient groups.
Participant Demographics
Patients included were newly diagnosed with serum M-protein, with exclusions for biclonal paraproteins and amyloidosis.
Statistical Information
P-Value
<0.001
Confidence Interval
0.706–0.883
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website